Citation Impact

Citing Papers

Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Stress Hormone-Related Psychopathology: Pathophysiological and Treatment Implications
2001
Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression
2002
Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: Markers that further explain the higher incidence of neurodegeneration and coronary artery disease
2010
Major depressive disorder is a risk factor for low bone mass, central obesity, and other medical conditions
2011
Clinical Subtypes of Depression Are Associated with Specific Metabolic Parameters and Circadian Endocrine Profiles in Women: The Power Study
2012
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
2012
Low 24-Hour Adiponectin and High Nocturnal Leptin Concentrations in a Case-Control Study of Community-Dwelling Premenopausal Women With Major Depressive Disorder
2010
Interferon-Induced Depression in Chronic Hepatitis C
2012
Depression
2018 Standout
Increased IgA and IgM responses against gut commensals in chronic depression: Further evidence for increased bacterial translocation or leaky gut
2012
Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells
2020 StandoutNobel
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders
2010
Pathophysiology of hypercortisolism in depression
2007
Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.
2009
TREATMENT OF ALOPECIA AREATA
1996
The Natural History of Neuroendocrine Changes in Pediatric Posttraumatic Stress Disorder (PTSD) After Motor Vehicle Accidents: Progressive Divergence of Noradrenaline and Cortisol Concentrations Over Time
2007
Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients
2010
Pharmacotherapy of somatoform disorders
2004
Perceived discrimination and health: A meta-analytic review.
2009 Standout
Attentional Bias for Psoriasis-Specific and Psychosocial Threat in Patients with Psoriasis
2003
Pathogenesis and clinical features of psoriasis
2007 Standout
The Role of β-Glucuronidase in Drug Disposition and Drug Targeting in Humans
1997
Alopecia Areata in Children: A Clinical Profile
2002
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences
2010
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
2011
Cushing's syndrome
2015 Standout
The Concept of Depression as a Dysfunction of the Immune System
2010
Levosulpiride in somatoform disorders: A double-blind, placebo-controlled cross-over study
2003
Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides
2014
Chronic fatigue syndrome criteria. A critique of the requirement for multiple physical complaints
1992
Psychiatric and Psychological Co-Morbidity in Patients with Dermatologic Disorders
2003
Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression
2010
Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder
1998
Expression of neuropeptide-degrading enzymes in alopecia areata: an immunohistochemical study
2001
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Alopecia areata update
2010 Standout
Development of Alopecia Areata Is Associated with Higher Central and Peripheral Hypothalamic–Pituitary–Adrenal Tone in the Skin Graft Induced C3H/HeJ Mouse Model
2008
Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
2009
Biological roles of glycans
2016 Standout
Inflammatory Biomarkers in Depression: An Opportunity for Novel Therapeutic Interventions
2011
Inflammation and depression: a causal or coincidental link to the pathophysiology?
2017
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
A Clinical Index for Rating Severity in Cushing’s Syndrome
2000
The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D)
2012
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Psoriasis
2015 Standout
Depression and risk of developing dementia
2011
Divergent Beliefs About Psoriasis Are Associated with Increased Psychological Distress
2004
Psoriasis causes as much disability as other major medical diseases
1999
Systemic Lupus Erythematosus
2011 Standout
Polyphenols: food sources and bioavailability
2004 Standout
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Psychosomatic Factors in First-Onset Alopecia Areata
2003
Neurobiology of Depression
2002 Standout
Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression
1997
Lifetime prevalence of psychiatric disorders in patients with alopecia areata
1991
Frailty: implications for clinical practice and public health
2019 Standout
Psychophysiology of Stress in Dermatology
1996
Affective Disorders and Endocrine Disease
1994
Corticotropin-releasing hormone in depression and post-traumatic stress disorder
2001
Major Depressive Disorder
2008 Standout
Major Depression and Activation of The Inflammatory Response System
1999
Rheumatoid arthritis
2010 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Depression gets old fast: do stress and depression accelerate cell aging?
2010
The role of psychological factors in alopecia areata and the impact of the disease on the quality of life
2004
Exercise Enhances Learning and Hippocampal Neurogenesis in Aged Mice
2005 Standout
Stress and disorders of the stress system
2009 Standout
Low Bone Mass in Premenopausal Women With Depression
2007
Functional Polymorphism of Cyclooxygenase-2 Gene (G–765C) in Depressive Patients
2010
AKT/PKB Signaling: Navigating the Network
2017 Standout
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being
2004
High levels of somatic DNA diversity at the myotonic dystrophy type 1 locus are driven by ultra-frequent expansion and contraction mutations
2012
The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
2010
Epilepsy and cognition
2003
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
The relation of stress and family environment to atopic dermatitis symptoms in children
1987
Cardiovascular reactivity of mitral valve prolapse patients during experimental stress exposure: evidence for a functional nature of cardiovascular symptoms
1996
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.
2007 Standout
A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity
2012
Schizophrenia: A neural diathesis-stress model.
1997
The molecular neurobiology of depression
2008 StandoutNature
Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
2019 StandoutNobel
Meditation states and traits: EEG, ERP, and neuroimaging studies.
2006 Standout
Can we vaccinate against depression?
2012
Adult brain neurogenesis and depression
2002
Stimulus-response paradigm for characterizing the loss of resilience in homeostatic regulation associated with frailty
2008
Clinically Significant Drug Interactions with Newer Antidepressants
2011
Prevention of Recurrent Depression With Cognitive Behavioral Therapy
1998
Stress and alopecia areata: a psychodermatologic study.
1997
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Children With Alopecia Areata: Psychiatric Symptomatology and Life Events
1997
Can Meditation Slow Rate of Cellular Aging? Cognitive Stress, Mindfulness, and Telomeres
2009 StandoutNobel
Gender differences in drug responses
2006
Influence of a Mindfulness Meditation-Based Stress Reduction Intervention on Rates of Skin Clearing in Patients With Moderate to Severe Psoriasis Undergoing Photo Therapy (UVB) and Photochemotherapy (PUVA)
1998
Optimizing well-being: The empirical encounter of two traditions.
2002 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Policy: NIH to balance sex in cell and animal studies
2014 StandoutNature
Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure.
1985
Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors.
1996 StandoutNobel
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
1994 Standout
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
Induction of hair growth by skin irritants and its relation to skin protein kinase C isoforms
1999
Impaired decision‐making and selective cortical frontal thinning in Cushing's syndrome
2014
Alopecia areata update
2000 Standout
Implications of long-term conditions for both mental and physical health: comparison of rheumatoid arthritis and schizophrenia
2009
Risky families: Family social environments and the mental and physical health of offspring.
2002 Standout
Alopecia areata update
2000
Controls of Hair Follicle Cycling
2001 Standout
Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression.
2011
Extrahelical (CAG)/(CTG) triplet repeat elements support proliferating cell nuclear antigen loading and MutLα endonuclease activation
2013 StandoutNobel
Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus
2000 Standout
Roles of Stress, Stress Perception and Trait‐Anxiety in the Onset and Course of Alopecia Areata
2003
The immunoregulatory effects of antidepressants
2001
EAT-4, a Homolog of a Mammalian Sodium-Dependent Inorganic Phosphate Cotransporter, Is Necessary for Glutamatergic Neurotransmission inCaenorhabditis elegans
1999 StandoutNobel
Frontal lobe dysfunction in secondary depression
1994

Works of Giulia Perini being referenced

Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia
2005
Cognitive impairment and (CTG)n expansion in myotonic dystrophy patients
1999
Volumetric MRI analysis of hippocampal subregions in Cushing's disease: A model for glucocorticoid neural modulation
2010
Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26
2006
Mood, cognition and EEG changes during interferon α (alpha-IFN) treatment for chronic hepatitis C
2004
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression
2008
Avoidable mortality of psychiatric patients in an area with a community‐based system of mental health care
2006
Imipramine in Alopecia Areata
1994
Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder
2005
Multiple-Dose Pharmacokinetics of Imipramine and Its Major Active and Conjugated Metabolites in Depressed Patients
1988
Life events and psychological distress in dermatologic disorders: Psoriasis, chronic urticaria and fungal infections
1980
Stress-responsive neurohormonal systems and the symptom complex of affective illness.
1989
Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.
1992
Interictal mood and personality disorders in temporal lobe epilepsy and juvenile myoclonic epilepsy.
1996
Rating depression in normals and depressives: Observer versus self-rating scales
1986
Psychoimmunoendocrine aspects of panic disorder
1995
Health-related quality of life in Italian patients with systemic lupus erythematosus
2004
The metyrapone test in affective disorders and schizophrenia
1984
Effects of glucocorticoid antagonism with RU 486 on pituitary-adrenal function in patients with major depression: time-dependent enhancement of plasma ACTH secretion.
1989
The dexamethasone suppression and metyrapone tests in depression
1985
The Metyrapone Test in Schizophrenic Patients and Healthy Subjects
1985
Effects of carbamazepine on pituitary-adrenal function in healthy volunteers
1992
The metyrapone test in affective disorders and schizophrenia II
1984
Life Events and Alopecia areata
1984
Hypochondriacal fears and beliefs in DSM-III melancholia Changes with amitriptyline
1986
Depression and Anxiety in Complex Partial Seizures
1984
Rankless by CCL
2026